Fucoxanthin, a carotenoid derived from edible marine algae, has been shown to increase UCP1 expression in the BAT of mice genetically predisposed to obesity and type 2 diabetes, thereby partially alleviating obesity symptoms [13]. The gene discussed is UCP1; the disease is obesity due to melanocortin 4 receptor deficiency.